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The exocellular DD-carboxypeptidases from Streptomyces R61, K 15, the lysozyme-releasable 
DD-carboxypeptidases from Streptomyces R61, K15 and rimosus, and the membrane-bound 
DD-carboxypeptidase of Streptomyces K15 are immunologically related to each other. 
As many as four enzymes may be involved in the 
peptidoglycan crosslinking enzyme system in Strepto- 
myces sp. [l]. Streptomyces K15 excretes an exocel- 
lular DD-carboxypeptidase ; it has two cell-bound 
DD-carboxypeptidases, one of which is released by 
protoplasting the mycelium whereas the other is 
bound to the plasma membrane; and finally it pos- 
sesses a transpeptidase which is also membrane- 
bound, The enzyme system in Streptomyes R61 is 
very similar except for the membrane-bound DD-car- 
boxypeptidase activity which is hardly detectable. 
Finally, the enzyme system in Streptomyces rimosus 
consists almost exclusively of a membrane-bound 
transpeptidase. Rabbits were immunized with the 
purified exocellular enzyme of Streptomjxes R61 and 
the antiserum thus obtained was used as a tool for 
the study of the relationship which might exist between 
these various enzymes. Two DD-carboxypeptidases 
unrelated to the preceding ones served as controls. 
One of them was the exocellular nn-carboxypeptidase 
from Actinomadura R39 [2,3]. I1 was selected because 
of the profound differences that occur in the type of 
interpeptide bridging in the wall peptidoglycans of the 
Streptomyces strains (a D-Ala-Gly-u-diaminopimelic 
acid linkage) and of Actinomadura R39 (a C-terminal 
D-Ala-(D)-meso-diaminopimelic acid linkage) [3 J. The 
other control en7yme was the exocellular DD-carboxy- 
peptidase from Streptomyces albus G which, in con- 
trast to the other Streptomyces exocellular DD-car- 
boxypeptidases, is a cationic protein, does not per- 
form transfer reactions, has a high lytic activity 
on various wall peptidoglycans and is largely insensi- 
tive to P-lactams [3]. 
MATERIALS AND METHODS 
Enzymes 
The exocellular enzymes from Streptomyces R61 
and Actinomadura R39 had been purified to protein 
homogeneity [2]. The exocellular enzyme from Strep- 
tomyces K 15 and the lysozyme-releasable enzymes 
from Streptomyces R61, K15 and rimosus were at 
various stages of purity as described by Leyh-Bouille 
et al. [I]. The cytoplasmic membranes from Strepto- 
myces R61, K1S and rirnosus were also prepared as 
described in [l]. The final membrane preparations 
contained about 25 mg proteinjml in 14 mM phos- 
phate buffer. Unless otherwise specified, the DD-car- 
boxypeptidase activity was estimated by using 1.6mM 
Ac2-L-Lys-D-Ala-D-Ala and the transpeptidase ac- 
tivity by using 1.6 mM Ac2-L-Lys-D-Ala-D-Ala 
+ 1.6 mM Gly-Gly. The techniques are those de- 
scribed previously [l]. 
Radioactive Benzylpenicillin 
[14C JBenzylpenicillin (with the label in the acyl 
side-chain ; 50 Cijmol) was purchased from the Radio- 
chemical Centre (Amersham). 
An tiserum 
A male New Zealand white rabbit (4-5 kg) 
served as the source of antiserum. The rabbit was 
injected with 2 mg R61 enzyme emulsified in 1.5 ml 
10 mM phosphate buffer, pH 7.5, and 1 .S ml of com- 
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plete Freund's adjuvant (Difco) into the hind foot 
pads, intramuscularly, and subcutaneously into the 
dorsum of the neck. Booster injections, each con- 
taining 1 mg enzyme, were administered in a similar 
fashion at 2, 6 and 8 weeks. The rabbit was 
exsanguinated from the marginal ear vein 10 weeks 
after the first injection and the serum obtained was 
decomplemented at 56 'C  for 30 min. When the en- 
zyme preparation (1 6 pg and 32 pg) was reacted against 
the serum in immunodiffusion analysis [4], a single 
precipitation band was detected. Normal-rabbit serum 
obtained prior to any immunization procedures served 
as the control serum. 
RESULTS 
Effects of Antiserum on the Activities 
of the Exocellular R61 Enzyme 
Enzyme (6 ng) and various amounts of either anti- 
serum or control serum (0.001 - 5 pl) were incubated 
together in 30 pl, final volume, of 8 mM Tris-HC1 
buffer pH 7.5 for 1 h at 37 "C. The DD-carboxy- 
peptidase activity was then estimated by incubating 
the reaction mixtures with 1.6 mM Acz-L-Lys-D-Ala- 
u-Ala for 4 h at 37 "C. The control serum had no 
effect. Maximal inhibition of the enzyme activity 
by the antiserum was of 80- 85 % (Fig. 1). In other 
experiments the enzyme activity was estimated by 
using larger concentrations of Acz-L-Lys-D-Ala-D-Ala 
up to 24 mM (i.e. 2 x the K, value) and by decreasing 
accordingly the incubation times in order to main- 
tain initial velocity measurements. The extents of 
enzyme inhibition effected by the various antiserum 
dilutions remained unchanged. Finally, the inhibition 
of the transpeptidase activity (as measured with 
1.6 mM Acz-L-Lys-D-Ala-D-Ala + 1.6 mM Gly-Gly) 
was found to parallel the inhibition of the DD-carboxy- 
peptidase activity. 
Effects ofAntiserum on the Penicillin-Binding Cupability 
of the Exocellular R61 Enzyme 
Enzyme (8.4 pg), various amounts of antiserum 
(2- 140 pl) and various amounts of control serum 
(0- 138 pI, with the result that all the reaction mixtures 
contained 140 p1 antiserum + control serum) were 
incubated together in 1040 pl, final volume, of 5 mM 
Tris-HC1 buffer pH 7.5, for 1 h at 37 "C. The ratios 
of enzyme protein to antiserum were identical to those 
used in the preceding experiments but in the present 
case there was a 40-fold increase in the absolute 
concentrations of the two reagents. Samples (2 pl) 
were removed and tested for residual enzyme activity 
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Fig.1. Effects of the anliserum to exocellulu~ R61 enzyme on the 
DD-cUrbo xypeptidase activity and penicillin-binding capability of the 
exocellufar R61 enzyme. (-0) Effect of control serum on the 
no-carboxypeptidase activity; (M) inhibition of uo-carboxy- 
peptidase activity under conditions where 6 ng enzyme and samples 
of antiserum (from 0.001 to 0.1 pl) were incubated together in 
30 PI, final volume; (M) inhibition of no-carboxypeptidase 
activity under conditions where 8.4 pg enzyme and samples of 
antiserum (from 2 to 140 pl) were incubated together in 1040 pl, 
final volume; (A-A) effect of the antiserum on the ability to 
bind ['4C]benzylpenicillin. For other cxperimcntal conditions, 
see text 
in 8 mM Tris-HC1 buffer pH 7.5 (final volume: 30 pl) 
for 90 min at 37 'C. All reaction mixtures were then 
supplemented with 0.6 nmol ['4C]benzylpenicillin and 
incubated for 15 min at 37 "C. Trichloroacetic acid 
( 5  ml of an 11 % solution) was added to each mixture 
at 0 "C to precipitate bound-penicillin-labelled pro- 
tein. The precipitates were collected by centrifugation, 
washed with 8 ml cold trichloroacetic acid solution, 
dried at 60 "C, solubilized with 1 ml of Soluene and 
the radioactivity was counted (in 10 ml Bray scintil- 
lation liquid). Non-specific trapping of radioactivity 
was estimated from solutions containing the same 
amounts of serum and antiserum as above but without 
enzyme. Fig. 1 shows that the loss of enzyme activity 
paralleled the loss of the ability of the enzyme to bind 
penicillin. 
Effects of Antiserum on the Activities 
of Enzymes Other than The Exocellulur R61 Enzyme 
The same microscale technique was used to assay 
inhibition of other soluble (exocellular or lysozyme- 
releasable) enzymes. The antiserum had no effect on 
the exocellular enzymes from both Actinomadura R39 
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Table 1. Effects of the antiserum to exocellular R61 enzyme on the ou-carboxypeptidase and transpeptidase activities qf the exocellular and 
lysozyme-releasuble enzymes 
The activities are expressed as percentages of the tripeptide Acz-L-Lys-D-Ala-D-Ala hydrolysed (DD-carboxypeptidase activity) or transformed 
into Acz-L-Lys-D-Ala-Gly-Gly (transpeptidase activity). All the enzyme/antiserum incubations were carried out at 37 "C and in 30 pl, 
final volumes. The buffers used were 5-10 mM Tris-HCI, pH 7.5; except for the exocellular enzyme from Streptomyces albus G (50 mM 
Tris-HCl pH 8.3 + 5 mM MgC12) and for the exocellular enzyme from Actinornadura R39 (30 mM Tris-HC1 pH 7.5 + 3 mM MgC12). The 
amounts of enzyme used were such that the activities measured in the absence of antiserum necessitated 4 h of incubation at 37 "C with the 
substrates, except for the lysozyme-releasable enzyme of Strrptomjves rimosus in which case the incubation time was of 18 h 
Strain Enzyme DD-Carhoxypeptidase activity: Transpeptidase activity: 
+ 3.6 mM Gly-Gly 
+ 8 mM Gly-Gly 
1.6 mM Acz-~-Lys-~-Ala-~-Ala  (a) 1.6 mM Ac*-L-Lys-D-Ala-D-Ala 
(b) 1.6 mM AQ-I -Lys-~-Ala-~-Ala 
activity antiserum activity activity antiserum activity 
in the present in the in the present in the 
abscncc in 30 p1 presence absence in 30 ~l presence 
of final of of final of 
antiserum volumes antiserum antiserum volumes antiserum 
Streptomyces K61 exocellular 
SlrepromyceA R61 lysozyme- 
releasable 
StrepptomyceJ K l 5  exocellular 
Streptomycer K25 lysozyme- 
relcasable 
Streptomyces rimosus lysozyme- 
Streptomyces albus G exocellular 
Actinomadura R39 exocellular 
releasable 
23 0.05 3.0 (a) 4 
(b) 10 
20 0.05 2.6 (a) 2.14 
(a) 2.25 
(b) 5.47 
20 0.05 1.8 (a) 3.35 
(a) 2.50 
(b) 6 
22 1 15.8 
10 1 2.5 
24 1 24 

















and Streptomyces albus G (Table 1). The lysozyme- 
releasable enzymes from strains R61, K15 and rimosus 
were inhibited by 70 - 90 both in the DD-carbOXy- 
peptidase and the transpeptidase assays. The exo- 
cellular enzyme from strain K15 was only inhibited 
by about 28%. This low extent of enzyme inhibition 
might be easily explained if one assumes that the 
second penicillin-binding component of Mr 62 000 
present in the K15 enzyme preparation [ I ]  is another 
Du-carboxypeptidase not related immunologically to 
the m-carboxypeptidase of M ,  38 000. 
The microscale system was modified to assay the 
effects of the antiserum on the membrane-bound 
enzymes. In this modification, membranes (1.8 mg 
protein), antiserum or control serum (dilution range : 
1/6 to 1/300) were incubated together in 14 mM phos- 
phate buffer pH 7.5 (final volume: 72 pl) for 1 h at 
37 "C and then for 18 h at 4 "C. Samples were removed 
and tested for DD-carboxypeptidase and transpeptidase 
activities. The experimental conditions and results 
are given in Table 2. Other than a slight inhibition 
(1 9 %) of the membrane-bound DD-carboxypeptidase 
activity of strain K15, the antiserum had no effect 
on the other membrane-bound enzymes tested. 
DISCUSSION 
The antiserum to exocellular R61 enzyme was 
found to inhibit the DD-carboxypeptidase and trans- 
peptidasc activities as well as the penicillin-binding 
capability of the exocellular R61 enzyme. This same 
antiserum was also found to inhibit the exocellular 
and lysozyme-releasable DD-carboxypeptidases from 
Streptomyces R61, K15 and rimosus. This observation 
suggests a certain structural relatedness for these 
enzymes. Whether the observed antigenic cross-reac- 
tivity is due to a similarity of the active sites or other 
areas of the enzyme molecules warrants further study. 
The antiserum to exocellular R61 enzyme had no effect 
on the activity of the membrane-bound transpeptidases 
of the three strains examined. It is known that a 
temperature as low as -30 "C is required to prevent 
the membranes of Streptomyces R63 from performing 
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Tablc 2. Effects of the antiserum to exocelhlar R61 enzyme on the 
on-carboxypeptiduse und transpeptidase activities of the membranes 
of Streptomyces R6-1, K15 and rimosus 
nn-Carboxypeptidase activity was estimated by incubating for 20 h 
at 37 "C, 25-p1 samples of the membrane/antiserum suspensions in 
30 PI. final volume, of 11 mM phosphate buffer, pH 7.5, in the 
presence of 4.7 mM Ac2-L-Lys-D-Aka-D-Ala. Depending upon the 
membranes, 4- 10 :< of the tripeptide was hydrolysed in the control 
samples. Transpeptidase activity was estimated by incubating for 
4 h at 37 "C, samples of the membrane/antiserum suspensions in 
30 pl. final volume, of 9 mM phosphate buffer pH 7.5, in the 
presence ol' 1.6 mM Ac2-L-Lys-u-Ala-n-Ala and 1.6 mM Gly-Gly. 
The volumes of the samples used were: (1) for strain R61: 2.5 pl 
(a), 1.25 p1 (b), 3 p1 (c); (2) for strain K15: 10 pl; and (3) for strain 
rimosus: 2.5 pl (d) and 2 p1 (e). Depending upon the cases, 
1.5-6.2 of the tripeptide was transformed into A c ~ - L - L ~ D -  
Ala-Gly-Gly in the control samples. The average value for all the 
residual activities in the presence of antiserum, except for the 
membrane-bound Dn-carboxypeptidase of strain K15, is 104% with 
a standard deviation value of 10. The average value for the K15 
residual Dwcarboxypeptidase activity is 81 with a standard 
deviation of 4 
transpeptidation reactions [ 5 ] .  Such a property sug- 
gests that the enzyme is deeply buried within the lipid 
phase of the membrane and for this reason, antigenic 
sites may be inaccessible to antibodies. Part of the 
DD-carboxypeptidase activity of the membranes of 
strain K15, however, was inhibited by the antiserum 
to exocellular R61 enzyme. It can thus be attributed 
to an enzyme which is distinct from the transpeptidase 
and is immunologically related to the exocellular 
and lysozyme-releasable enzymes. 
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